Literature DB >> 24045386

Factors influencing bone mineral density in ARV-naive patients at Sanglah Hospital, Bali.

Sri Masyeni1, Susila Utama, Agus Somia, Raka Widiana, Tuti P Merati.   

Abstract

AIM: to evaluate factors which influence bone mineral density in ARV-naive patients in Sanglah Hospital, Bali.
METHODS: a cross-sectional BMD measured by dual X-ray absorptiometry at the lumbar spine (LS) and femoral neck (FN) in 73 ARV-naive HIV-infected patients in out patient clinic of Sanglah Hospital, consecutively, from January to June 2012. Inclusion criteria are ARV-naive HIV-infected patients age 13-50 year old. The relationship among factors influence BMD, CD4 level, HIV RNA, HIV stage (WHO) analysed with Anova and Spearman's correlation test.
RESULTS: this study involved 49 males and 24 females. Mean age was 33.08±8.29. Mean CD4 was 144.71±143.40 cell/mmc with the lowest CD4 is 1. Mean viral load (VL) was 272.330±282.990 copies/ml, the lowest VL 400 copies/ml, and the highest 750 000 copies/ml. Low BMD found in 32/73 (43.8%). Osteopenia and osteoporosis were diagnosed in 26/73 (35.6%) and 6/73 (8.2%). 13 (40.6%) of the low BMD cases occurred on the age group 21-30 year. Significant correlation found between low BMD with HIV stage (r=0.337; p<0.001).
CONCLUSION: patients with higher HIV stage have higher risk of low BMD in ARV-naive patient. Further study is needed to evaluate correlation of low BMD with its risk factors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24045386

Source DB:  PubMed          Journal:  Acta Med Indones        ISSN: 0125-9326


  6 in total

1.  Bone alterations associated with HIV.

Authors:  Amy H Warriner; Michael Mugavero; E Turner Overton
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

2.  Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Authors:  A Carr; B Grund; J Neuhaus; A Schwartz; J I Bernardino; D White; S Badel-Faesen; A Avihingsanon; K Ensrud; J Hoy
Journal:  HIV Med       Date:  2015-04       Impact factor: 3.180

3.  Bone Loss in HIV Infection.

Authors:  Caitlin A Moran; M Neale Weitzmann; Ighovwerha Ofotokun
Journal:  Curr Treat Options Infect Dis       Date:  2017-02-23

4.  Low bone mass in people living with HIV on long-term anti-retroviral therapy: A single center study in Uganda.

Authors:  Erisa Sabakaki Mwaka; Ian Guyton Munabi; Barbara Castelnuovo; Arvind Kaimal; William Kasozi; Andrew Kambugu; Philippa Musoke; Elly Katabira
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

Review 5.  Bone health and HIV in resource-limited settings: a scoping review.

Authors:  Flavia Kiweewa Matovu; Lalita Wattanachanya; Mags Beksinska; John M Pettifor; Kiat Ruxrungtham
Journal:  Curr Opin HIV AIDS       Date:  2016-05       Impact factor: 4.283

6.  Evaluation of antiretroviral effect on mitochondrial DNA depletion among HIV-infected patients in Bali.

Authors:  Sri Masyeni; Erly Sintya; Dewi Megawati; Ni Made Hegard Sukmawati; Dewa Ga Budiyasa; Sri Agung Aryastuti; Siti Qamariyah Khairunisa; Igkn Arijana; N Nasronudin
Journal:  HIV AIDS (Auckl)       Date:  2018-07-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.